Skip to main navigation Skip to search Skip to main content

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)

  • Hatef Darabi
  • , Jonathan Beesley
  • , Arnaud Droit
  • , Siddhartha Kar
  • , Silje Nord
  • , Mahdi Moradi Marjaneh
  • , Penny Soucy
  • , Kyriaki Michailidou
  • , Maya Ghoussaini
  • , Hanna Fues Wahl
  • , Manjeet K. Bolla
  • , Qin Wang
  • , Joe Dennis
  • , M. Rosario Alonso
  • , Irene L. Andrulis
  • , Hoda Anton-Culver
  • , Volker Arndt
  • , Matthias W. Beckmann
  • , Javier Benitez
  • , Natalia V. Bogdanova
  • Stig E. Bojesen, Hiltrud Brauch, Hermann Brenner, Annegien Broeks, Thomas Brüning, Barbara Burwinkel, Jenny Chang-Claude, Ji Yeob Choi, Don M. Conroy, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Peter Devilee, Thilo Dörk, Douglas F. Easton, Peter A. Fasching, Jonine Figueroa, Olivia Fletcher, Henrik Flyger, Eva Galle, Montserrat García-Closas, Graham G. Giles, Mark S. Goldberg, Anna González-Neira, Pascal Guénel, Christopher A. Haiman, Emily Hallberg, Ute Hamann, Mikael Hartman, Antoinette Hollestelle, John L. Hopper, Hidemi Ito, Anna Jakubowska, Nichola Johnson, Daehee Kang, Sofia Khan, Veli Matti Kosma, Mieke Kriege, Vessela Kristensen, Diether Lambrechts, Loic Le Marchand, Soo Chin Lee, Annika Lindblom, Artitaya Lophatananon, Jan Lubinski, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Keitaro Matsuo, Rebecca Mayes, James McKay, Alfons Meindl, Roger L. Milne, Kenneth Muir, Susan L. Neuhausen, Heli Nevanlinna, Curtis Olswold, Nick Orr, Paolo Peterlongo, Guillermo Pita, Katri Pylkäs, Anja Rudolph, Suleeporn Sangrajrang, Elinor J. Sawyer, Marjanka K. Schmidt, Rita K. Schmutzler, Caroline Seynaeve, Mitul Shah, Chen Yang Shen, Xiao Ou Shu, Melissa C. Southey, Daniel O. Stram, Harald Surowy, Anthony Swerdlow, Soo H. Teo, Daniel C. Tessier, Ian Tomlinson, Diana Torres, Thérèse Truong, Celine M. Vachon, Daniel Vincent, Robert Winqvist, Anna H. Wu, Pei Ei Wu, Cheng Har Yip, Wei Zheng, Paul D.P. Pharoah, Per Hall, Stacey L. Edwards, Jacques Simard, Juliet D. French, Georgia Chenevix-Trench, Alison M. Dunning
  • Karolinska Institutet
  • Queensland Institute of Medical Research
  • Research Center
  • University of Cambridge
  • University of Oslo
  • Cyprus Institute of Neurology and Genetics
  • Centro de Investigación en Red de Enfermedades Raras
  • University of Toronto
  • University of California, Irvine
  • German Cancer Research Center
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Centre for Biomedical Research on Rare Diseases (CIBERER)
  • Hannover Medical School
  • Copenhagen University Hospital – Herlev and Gentofte
  • University of Copenhagen
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • University of Tübingen
  • Antoni van Leeuwenhoek Hospital
  • Ruhr University Bochum
  • Heidelberg University 
  • University of Hamburg
  • Seoul National University
  • Mayo Clinic Rochester, MN
  • University of Sheffield
  • Leiden University
  • University of California at Los Angeles
  • University of Edinburgh
  • National Cancer Institute (NCI)
  • Institute of Cancer Research
  • Vesalius Research Center
  • KU Leuven
  • Cancer Council Victoria
  • Centre for Epidemiology and Biostatistics
  • McGill University
  • McGill University Health Centre, Royal Victoria Hospital
  • Occupational and Social Determinants of Health
  • Keck School of Medicine of USC
  • National University of Singapore
  • MOH Holdings Pte Ltd.
  • Erasmus MC Cancer Institute
  • Aichi Cancer Center Hospital and Research Institute
  • Pomeranian Medical University in Szczecin
  • Helsinki University Hospital
  • University of Eastern Finland
  • University of Hawaii Cancer Center
  • University of Warwick
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • International Agency for Research on Cancer
  • Technical University of Munich
  • University of Manchester
  • City of Hope National Med Center
  • FIRC Institute of Molecular Oncology
  • University of Oulu
  • Northern Finland Laboratory Centre NordLab
  • The National Cancer Institute
  • Guy’s Hospital
  • University of Cologne
  • Universität zu Köln
  • Academia Sinica - Institute of Biomedical Sciences
  • Vanderbilt University
  • University of Melbourne
  • Sime Darby Medical Centre
  • University of Malaya
  • University of Oxford

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Genome-wide association studies have found SNPs at 17q22 to be associated with breast cancer risk. To identify potential causal variants related to breast cancer risk, we performed a high resolution fine-mapping analysis that involved genotyping 517 SNPs using a custom Illumina iSelect array (iCOGS) followed by imputation of genotypes for 3,134 SNPs in more than 89,000 participants of European ancestry from the Breast Cancer Association Consortium (BCAC). We identified 28 highly correlated common variants, in a 53 Kb region spanning two introns of the STXBP4 gene, that are strong candidates for driving breast cancer risk (lead SNP rs2787486 (OR = 0.92; CI 0.90-0.94; P = 8.96 × 1015)) and are correlated with two previously reported risk-associated variants at this locus, SNPs rs6504950 (OR = 0.94, P = 2.04 × 1009, r2 = 0.73 with lead SNP) and rs1156287 (OR = 0.93, P = 3.41 × 1011, r2 = 0.83 with lead SNP). Analyses indicate only one causal SNP in the region and several enhancer elements targeting STXBP4 are located within the 53 kb association signal. Expression studies in breast tumor tissues found SNP rs2787486 to be associated with increased STXBP4 expression, suggesting this may be a target gene of this locus.

Original languageEnglish
Article number32512
JournalScientific Reports
Volume6
DOIs
StatePublished - 07 Sep 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)'. Together they form a unique fingerprint.

Cite this